Bonsity Approval Expands Treatment Options for Osteoporosis

σε πρόσθεσε στο Health

2026-10-01 06:30:49 - Μετάφραση -

Osteoporosis is a chronic skeletal condition in which reduced bone strength increases the likelihood of fractures, particularly among older adults. The U.S. Food and Drug Administration (FDA) approved bonsity, also known as PF708 or teriparatide injection, for certain patients with osteoporosis who face a high risk of fracture. The product was reviewed using Forteo as its reference product,...

0 Σχόλια 0 Μοιράστηκε 9 Views 0 Προεπισκόπηση